Effect of imatinib on philadelphia chromosome positive acute lymphoblastic leukemia
收藏官方服务：
资源简介：
Effect of imatinib on philadelphia chromosome positive acute lymphoblastic leukemia
应用场景：
创建时间：
2010-09-10
相关数据集
Targeting a newly-identified RNA polymerase II-associated PHF5A-PHF14-KMT2A transcriptional subcomplex with a KMT2A-WDR5 inhibitor impairs the self-renewal, pluripotency and in vivo tumorigenicity of pancreatic cancer stem cells
Pancreatic cancer remains one of the most aggressive and lethal cancers in humans. It is undeniably known for its notorious resistance to conventional chemotherapeutics which are often associated with
NIAID Data Ecosystem70
Systemic oxaliplatin or in intra-arterial chemotherapy combined with LV5FU2 +/- Irinotecan and targeted therapy in first-line treatment of metastatic colorectal cancer restricted to the liver
Primary objectives: Comparison of radiological and/or clinical progression free survival between the arm with intraarterial oxaliplatin administration (Arms A and C) and those with intravenous oxalipl
NIAID Data Ecosystem60
Inactivation of p21-Activated Kinase 2 (Pak2) Inhibits the Development of Nf2-Deficient Tumors by Restricting Downstream Hedgehog and Wnt Signaling
Since loss of the NF2 tumor suppressor gene results in p21-activated kinase (Pak) activation, PAK inhibitors hold promise for the treatment of NF2-deficient tumors. To test this possibility, we asked
NIAID Data Ecosystem50
PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies [ChIP-seq]. Homo sapiens
The polycomb repressive complex 2 (PRC2) exerts oncogenic effects in many tumour types1. However, loss-of-function mutations in PRC2 components occur in a subset of haematopoietic malignancies, sugges
NIAID Data Ecosystem60
Additional file 1 of Cancer of unknown primary with EGFR mutation successfully treated with targeted therapy directed by clinical next-generation sequencing: a case report
Additional file 1: Supplementary Table 1. Target genes of the comprehensive genomic analysis.
NIAID Data Ecosystem50
